増加した眼内圧に対するプロスタグランジン薬の有効性と安全性:ベイジアンネットワークのメタ分析
Jieting Peng1, Wenrui Huang2, Junguo Duan3
1Chengdu University of Traditional Chinese Medicine, Affiliated Eye Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Frontiers in medicine
|August 27, 2025
まとめ
ビマトプロストは最も効果的に眼内圧 (IOP) を低下させますが,高血圧のリスクを高めます. ラタノプロストとタフループロストは,軽度の緑内障の治療にバランスの取れた有効性と耐容性を示しています.
科学分野:
- 眼科について
- 薬理学について
背景:
- 緑内障と眼高血圧は,眼内圧 (IOP) の効果的な管理を必要とします.
- ラタノプロスト,ビマトプロスト,トラボプロスト,タフロプロストなどのプロスタグランジン類は一般的な治療法です.
研究 の 目的:
- 4つのプロスタグランディン類の内血圧の低下における有効性と安全性を比較する.
- これらの薬剤に関連した結膜高血症のリスクを評価する.
主な方法:
- 4045人の参加者を含む25件のランダム化対照試験 (RCT) のベイジアンネットワークメタ解析.
- 2025年4月まで発表されたRCTの主要なデータベースを検索した.
- 確立された枠組みを用いて研究の質と証拠の確実性を評価する.
主要な成果:
- ビマトプロストは,ラタノプロストとトラボプロスト (中等から低い信頼度) と比較して最も顕著な内血圧低下を示した.
- ビマトプロストとトラボプロストは,ラタノプロストよりも結膜高血症のリスクが高く (高い信頼度).
- IOPの低下に関する証拠の質は,低から中程度でした.
結論:
- ビマトプロストは内血圧を下げるのに優れているが,高血圧のリスクは増加している.
- ラタノプロストとタフループロストは,軽度の症例に適した有効性と耐性のバランスをとります.
- 治療の選択は,個々の患者の要因とリスクプロフィールを考慮する必要があります.
関連する概念動画
01:27Open Angle Glaucoma: Treatment
561
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
561
01:25Glaucoma: Overview
749
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
749
01:28Angle Closure Glaucoma: Treatment
674
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
674
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
252
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
252
01:20Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
595
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
595
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
645
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
645